Skip to main content
Watch Insiders

Corporate insider profile

Jonathan Allan Insider Trades

Latest reported as GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. (STOK).

Purchase filings
0
Reported companies
1
Net open-market value
-$151,785.61
Latest transaction
Oct 2, 2026

Affiliated corporations

Reported company relationships

STOKLatest reported

Stoke Therapeutics, Inc.

GENERAL COUNSEL & CORP SEC

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 2, 2026Stoke Therapeutics, Inc. (STOK)GENERAL COUNSEL & CORP SECSale627$26.33$16,509
Aug 18, 2026Stoke Therapeutics, Inc. (STOK)GENERAL COUNSEL & CORP SECSale2,861$32.03$91,640
Jun 16, 2026Stoke Therapeutics, Inc. (STOK)GENERAL COUNSEL & CORP SECSale1,457$29.95$43,637